This webinar will discuss these approaches to spatial analysis and include an example of both protein and mRNA assessment of tissue using DSP as a biomarker discovery tool.

Register for this webinar to understand Why spatial relationships are important in tumour biology.

Pathology testing is helping to bring more clarity about disease and treatments to patients across the world. The insights that new techniques bring in this field are time sensitive, yet, these complex workflows often rely heavily on lab staff, repetitive manual steps, and have issues scaling.

In this webinar, Dr. Amelie Bonafond will present the current sequencing (via whole-exome sequencing) of all the patients with common T2D visiting the department of Diabetology of Liège Hospital (n > 4000 participants).

Inhibitors of the programmed cell death-1 (PD-1/PD-L1) signaling axis are approved to treat non-small cell lung cancer (NSCLC) patients. However, most NSCLC patients do not respond to PD-(L)1 blockade as single agents, and intratumoral immune infiltrates involved in the response to these therapies remain poorly characterized.

Patients diagnosed with CML 20 years ago could live for around five years.